Products

TheInfoTracer.com

Guided by Purpose: The Core of Everything We Do

theinfotracer.com Source★ 19Apache-2.0Entertainment & Media / News & Media

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
2y ago
2024-05-01 · Est.

Traffic

Monthly visitsData through Oct 2026
Events1 change

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    May 1, 2024 · 2y agoWebsite

Open Source & Self-Hosting

GitHub · MCP / Skill
Last commit 2026-10-30
GitHub Stars
★ 19
Forks
12
License
Apache-2.0
Primary language
JavaScript

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-05-01

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-11-04

Key pages

Weekly snapshots
theinfotracer.com/ Snapshot 2026-11-05

Changes

  1. Nov 1 · 18d ago

    Adopted technology: OneTrustFeatures

    —→OneTrust

    At the time: <5K visits/mo

Questions & evidence

How much website traffic does TheInfoTracer.com get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is TheInfoTracer.com and what platforms does it support?
TheInfoTracer.com is catalogued under News & Media: Guided by Purpose: The Core of Everything We Do. Supported platforms: Web.
Is TheInfoTracer.com open source?
TheInfoTracer.com has a public repository (https://github.com/newrelic/newrelic-browser-agent) under the Apache-2.0 license, recording 19 GitHub stars.Source

Related products in this category

Entertainment & Media / News & Media

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.